HEalth-Related Quality of Life-Intervention in Survivors of Breast and Other Cancers Experiencing Cancer-Related Fatigue and Associated Cognitive Symptoms Using TraditionAL Chinese Medicine: The ‘HERBAL’ Trial

Introduction: As pharmacological strategies remain limited for relieving fatigue and associated cognitive symptoms, integrative modalities such as traditional Chinese medicine (TCM) could be explored as therapeutic strategies in cancer survivors. Here, we evaluate and report the efficacy and safety...

Full description

Saved in:
Bibliographic Details
Main Authors: Alexandre Chan PharmD, Daniella Chan BS, Ding Quan Ng BSPharm, Huang Fang Zheng MD, Quan Ming Tan MCM, Chia Jie Tan PhD, Jolene Hui Min Toh BS, Ning Yi Yap PhD, Yi Long Toh PhD, Yu Ke PhD, Edmund Chun Ann Wang BS, Queenie Pei Ni Lim BSocSc, Han Kiat Ho PhD, Lita Chew MMS, Tira J. Tan MBBS
Format: Article
Language:English
Published: SAGE Publishing 2025-01-01
Series:Integrative Cancer Therapies
Online Access:https://doi.org/10.1177/15347354251314514
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832591278613725184
author Alexandre Chan PharmD
Daniella Chan BS
Ding Quan Ng BSPharm
Huang Fang Zheng MD
Quan Ming Tan MCM
Chia Jie Tan PhD
Jolene Hui Min Toh BS
Ning Yi Yap PhD
Yi Long Toh PhD
Yu Ke PhD
Edmund Chun Ann Wang BS
Queenie Pei Ni Lim BSocSc
Han Kiat Ho PhD
Lita Chew MMS
Tira J. Tan MBBS
author_facet Alexandre Chan PharmD
Daniella Chan BS
Ding Quan Ng BSPharm
Huang Fang Zheng MD
Quan Ming Tan MCM
Chia Jie Tan PhD
Jolene Hui Min Toh BS
Ning Yi Yap PhD
Yi Long Toh PhD
Yu Ke PhD
Edmund Chun Ann Wang BS
Queenie Pei Ni Lim BSocSc
Han Kiat Ho PhD
Lita Chew MMS
Tira J. Tan MBBS
author_sort Alexandre Chan PharmD
collection DOAJ
description Introduction: As pharmacological strategies remain limited for relieving fatigue and associated cognitive symptoms, integrative modalities such as traditional Chinese medicine (TCM) could be explored as therapeutic strategies in cancer survivors. Here, we evaluate and report the efficacy and safety of a TCM concoction, modified Xiang Bei Yang Rong Tang (XBYRT), on quality of life (QOL), cancer-related fatigue (CRF), and cognitive symptoms, compared to placebo. Methods: In a single-centered, randomized, double-blinded, placebo-controlled pilot trial conducted from 2019 to 2022, fatigued cancer survivors ≥21 years old were recruited to receive the XBYRT intervention or placebo (5% diluted) once daily for the duration of 8 weeks. Patient-reported outcomes for QOL, CRF, cognition, blood samples for biomarker testing, and adverse events were collected at baseline (T0), 4 weeks (T1), 8 weeks (T2), and 10 weeks (T3) after baseline. Linear regression was performed to evaluate differences between groups at T2 and T3. Results: A total of 1502 patients were screened, with 672 patients considered eligible. Of the eligible, 15 XBYRT and 13 placebo subjects with similar mean ages (58.5 vs 58.4) were recruited. Both groups were predominantly Chinese (93% vs 62%), breast cancer patients (87% vs 62%), and diagnosed with stage 2 cancer (60% vs 46%). Although no significant difference was found in QOL between groups, the XBYRT group exhibited improved emotional fatigue at T3 ( P  = .045) and higher BDNF levels at T2 ( P  = .047) and T3 ( P  = .029). After baseline adjustment, XBYRT was associated with better perceived cognitive impairment at T2 ( P  = .011) and T3 ( P  = .017), as well as overall perceived cognitive function at T3 ( P  = .028). XBYRT is well tolerated, with grade 3 adverse events reported in three XBYRT (20%) and two placebo (15%) subjects. Conclusion: In this pilot study, XBYRT as an integrative therapy is safe and generates encouraging improvements in cognitive and fatigue symptoms. Difficulties with recruitment limited the generalizability of trial findings, thus findings should be verified through a larger, multi-centered trial.
format Article
id doaj-art-0184326d92374fc8beb3994006405b5e
institution Kabale University
issn 1552-695X
language English
publishDate 2025-01-01
publisher SAGE Publishing
record_format Article
series Integrative Cancer Therapies
spelling doaj-art-0184326d92374fc8beb3994006405b5e2025-01-22T14:03:30ZengSAGE PublishingIntegrative Cancer Therapies1552-695X2025-01-012410.1177/15347354251314514HEalth-Related Quality of Life-Intervention in Survivors of Breast and Other Cancers Experiencing Cancer-Related Fatigue and Associated Cognitive Symptoms Using TraditionAL Chinese Medicine: The ‘HERBAL’ TrialAlexandre Chan PharmD0Daniella Chan BS1Ding Quan Ng BSPharm2Huang Fang Zheng MD3Quan Ming Tan MCM4Chia Jie Tan PhD5Jolene Hui Min Toh BS6Ning Yi Yap PhD7Yi Long Toh PhD8Yu Ke PhD9Edmund Chun Ann Wang BS10Queenie Pei Ni Lim BSocSc11Han Kiat Ho PhD12Lita Chew MMS13Tira J. Tan MBBS14University of California Irvine, Irvine, CA, USAUniversity of California Irvine, Irvine, CA, USAUniversity of California Irvine, Irvine, CA, USASingapore Thong Chai Medical Institution, Singapore, SingaporeSingapore Thong Chai Medical Institution, Singapore, SingaporeUniversity of Utah, Salt Lake City, UT, USANational University of Singapore, Singapore, SingaporeSubang Jaya Medical Centre, Subang Jaya, MalaysiaNational University of Singapore, Singapore, SingaporeNational Cancer Centre Singapore, SingaporeNational Cancer Centre Singapore, SingaporeNational Cancer Centre Singapore, SingaporeNational University of Singapore, Singapore, SingaporeNational University of Singapore, Singapore, SingaporeNational Cancer Centre Singapore, SingaporeIntroduction: As pharmacological strategies remain limited for relieving fatigue and associated cognitive symptoms, integrative modalities such as traditional Chinese medicine (TCM) could be explored as therapeutic strategies in cancer survivors. Here, we evaluate and report the efficacy and safety of a TCM concoction, modified Xiang Bei Yang Rong Tang (XBYRT), on quality of life (QOL), cancer-related fatigue (CRF), and cognitive symptoms, compared to placebo. Methods: In a single-centered, randomized, double-blinded, placebo-controlled pilot trial conducted from 2019 to 2022, fatigued cancer survivors ≥21 years old were recruited to receive the XBYRT intervention or placebo (5% diluted) once daily for the duration of 8 weeks. Patient-reported outcomes for QOL, CRF, cognition, blood samples for biomarker testing, and adverse events were collected at baseline (T0), 4 weeks (T1), 8 weeks (T2), and 10 weeks (T3) after baseline. Linear regression was performed to evaluate differences between groups at T2 and T3. Results: A total of 1502 patients were screened, with 672 patients considered eligible. Of the eligible, 15 XBYRT and 13 placebo subjects with similar mean ages (58.5 vs 58.4) were recruited. Both groups were predominantly Chinese (93% vs 62%), breast cancer patients (87% vs 62%), and diagnosed with stage 2 cancer (60% vs 46%). Although no significant difference was found in QOL between groups, the XBYRT group exhibited improved emotional fatigue at T3 ( P  = .045) and higher BDNF levels at T2 ( P  = .047) and T3 ( P  = .029). After baseline adjustment, XBYRT was associated with better perceived cognitive impairment at T2 ( P  = .011) and T3 ( P  = .017), as well as overall perceived cognitive function at T3 ( P  = .028). XBYRT is well tolerated, with grade 3 adverse events reported in three XBYRT (20%) and two placebo (15%) subjects. Conclusion: In this pilot study, XBYRT as an integrative therapy is safe and generates encouraging improvements in cognitive and fatigue symptoms. Difficulties with recruitment limited the generalizability of trial findings, thus findings should be verified through a larger, multi-centered trial.https://doi.org/10.1177/15347354251314514
spellingShingle Alexandre Chan PharmD
Daniella Chan BS
Ding Quan Ng BSPharm
Huang Fang Zheng MD
Quan Ming Tan MCM
Chia Jie Tan PhD
Jolene Hui Min Toh BS
Ning Yi Yap PhD
Yi Long Toh PhD
Yu Ke PhD
Edmund Chun Ann Wang BS
Queenie Pei Ni Lim BSocSc
Han Kiat Ho PhD
Lita Chew MMS
Tira J. Tan MBBS
HEalth-Related Quality of Life-Intervention in Survivors of Breast and Other Cancers Experiencing Cancer-Related Fatigue and Associated Cognitive Symptoms Using TraditionAL Chinese Medicine: The ‘HERBAL’ Trial
Integrative Cancer Therapies
title HEalth-Related Quality of Life-Intervention in Survivors of Breast and Other Cancers Experiencing Cancer-Related Fatigue and Associated Cognitive Symptoms Using TraditionAL Chinese Medicine: The ‘HERBAL’ Trial
title_full HEalth-Related Quality of Life-Intervention in Survivors of Breast and Other Cancers Experiencing Cancer-Related Fatigue and Associated Cognitive Symptoms Using TraditionAL Chinese Medicine: The ‘HERBAL’ Trial
title_fullStr HEalth-Related Quality of Life-Intervention in Survivors of Breast and Other Cancers Experiencing Cancer-Related Fatigue and Associated Cognitive Symptoms Using TraditionAL Chinese Medicine: The ‘HERBAL’ Trial
title_full_unstemmed HEalth-Related Quality of Life-Intervention in Survivors of Breast and Other Cancers Experiencing Cancer-Related Fatigue and Associated Cognitive Symptoms Using TraditionAL Chinese Medicine: The ‘HERBAL’ Trial
title_short HEalth-Related Quality of Life-Intervention in Survivors of Breast and Other Cancers Experiencing Cancer-Related Fatigue and Associated Cognitive Symptoms Using TraditionAL Chinese Medicine: The ‘HERBAL’ Trial
title_sort health related quality of life intervention in survivors of breast and other cancers experiencing cancer related fatigue and associated cognitive symptoms using traditional chinese medicine the herbal trial
url https://doi.org/10.1177/15347354251314514
work_keys_str_mv AT alexandrechanpharmd healthrelatedqualityoflifeinterventioninsurvivorsofbreastandothercancersexperiencingcancerrelatedfatigueandassociatedcognitivesymptomsusingtraditionalchinesemedicinetheherbaltrial
AT daniellachanbs healthrelatedqualityoflifeinterventioninsurvivorsofbreastandothercancersexperiencingcancerrelatedfatigueandassociatedcognitivesymptomsusingtraditionalchinesemedicinetheherbaltrial
AT dingquanngbspharm healthrelatedqualityoflifeinterventioninsurvivorsofbreastandothercancersexperiencingcancerrelatedfatigueandassociatedcognitivesymptomsusingtraditionalchinesemedicinetheherbaltrial
AT huangfangzhengmd healthrelatedqualityoflifeinterventioninsurvivorsofbreastandothercancersexperiencingcancerrelatedfatigueandassociatedcognitivesymptomsusingtraditionalchinesemedicinetheherbaltrial
AT quanmingtanmcm healthrelatedqualityoflifeinterventioninsurvivorsofbreastandothercancersexperiencingcancerrelatedfatigueandassociatedcognitivesymptomsusingtraditionalchinesemedicinetheherbaltrial
AT chiajietanphd healthrelatedqualityoflifeinterventioninsurvivorsofbreastandothercancersexperiencingcancerrelatedfatigueandassociatedcognitivesymptomsusingtraditionalchinesemedicinetheherbaltrial
AT jolenehuimintohbs healthrelatedqualityoflifeinterventioninsurvivorsofbreastandothercancersexperiencingcancerrelatedfatigueandassociatedcognitivesymptomsusingtraditionalchinesemedicinetheherbaltrial
AT ningyiyapphd healthrelatedqualityoflifeinterventioninsurvivorsofbreastandothercancersexperiencingcancerrelatedfatigueandassociatedcognitivesymptomsusingtraditionalchinesemedicinetheherbaltrial
AT yilongtohphd healthrelatedqualityoflifeinterventioninsurvivorsofbreastandothercancersexperiencingcancerrelatedfatigueandassociatedcognitivesymptomsusingtraditionalchinesemedicinetheherbaltrial
AT yukephd healthrelatedqualityoflifeinterventioninsurvivorsofbreastandothercancersexperiencingcancerrelatedfatigueandassociatedcognitivesymptomsusingtraditionalchinesemedicinetheherbaltrial
AT edmundchunannwangbs healthrelatedqualityoflifeinterventioninsurvivorsofbreastandothercancersexperiencingcancerrelatedfatigueandassociatedcognitivesymptomsusingtraditionalchinesemedicinetheherbaltrial
AT queeniepeinilimbsocsc healthrelatedqualityoflifeinterventioninsurvivorsofbreastandothercancersexperiencingcancerrelatedfatigueandassociatedcognitivesymptomsusingtraditionalchinesemedicinetheherbaltrial
AT hankiathophd healthrelatedqualityoflifeinterventioninsurvivorsofbreastandothercancersexperiencingcancerrelatedfatigueandassociatedcognitivesymptomsusingtraditionalchinesemedicinetheherbaltrial
AT litachewmms healthrelatedqualityoflifeinterventioninsurvivorsofbreastandothercancersexperiencingcancerrelatedfatigueandassociatedcognitivesymptomsusingtraditionalchinesemedicinetheherbaltrial
AT tirajtanmbbs healthrelatedqualityoflifeinterventioninsurvivorsofbreastandothercancersexperiencingcancerrelatedfatigueandassociatedcognitivesymptomsusingtraditionalchinesemedicinetheherbaltrial